BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17551084)

  • 21. A high incidence of WT1 abnormality in bilateral Wilms tumours in Japan, and the penetrance rates in children with WT1 germline mutation.
    Kaneko Y; Okita H; Haruta M; Arai Y; Oue T; Tanaka Y; Horie H; Hinotsu S; Koshinaga T; Yoneda A; Ohtsuka Y; Taguchi T; Fukuzawa M
    Br J Cancer; 2015 Mar; 112(6):1121-33. PubMed ID: 25688735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency and heritability of WT1 mutations in nonsyndromic Wilms' tumor patients: a UK Children's Cancer Study Group Study.
    Little SE; Hanks SP; King-Underwood L; Jones C; Rapley EA; Rahman N; Pritchard-Jones K
    J Clin Oncol; 2004 Oct; 22(20):4140-6. PubMed ID: 15483024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Duplication of paternal IGF2 or loss of maternal IGF2 imprinting occurs in half of Wilms tumors with various structural WT1 abnormalities.
    Haruta M; Arai Y; Sugawara W; Watanabe N; Honda S; Ohshima J; Soejima H; Nakadate H; Okita H; Hata J; Fukuzawa M; Kaneko Y
    Genes Chromosomes Cancer; 2008 Aug; 47(8):712-27. PubMed ID: 18464243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. WTX inactivation is a frequent, but late event in Wilms tumors without apparent clinical impact.
    Wegert J; Wittmann S; Leuschner I; Geissinger E; Graf N; Gessler M
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1102-11. PubMed ID: 19760609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic and epigenetic alterations on the short arm of chromosome 11 are involved in a majority of sporadic Wilms' tumours.
    Satoh Y; Nakadate H; Nakagawachi T; Higashimoto K; Joh K; Masaki Z; Uozumi J; Kaneko Y; Mukai T; Soejima H
    Br J Cancer; 2006 Aug; 95(4):541-7. PubMed ID: 16909133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nephron Progenitor But Not Stromal Progenitor Cells Give Rise to Wilms Tumors in Mouse Models with β-Catenin Activation or Wt1 Ablation and Igf2 Upregulation.
    Huang L; Mokkapati S; Hu Q; Ruteshouser EC; Hicks MJ; Huff V
    Neoplasia; 2016 Feb; 18(2):71-81. PubMed ID: 26936393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significant reduction of WT1 gene expression, possibly due to epigenetic alteration in Wilms' tumor.
    Satoh Y; Nakagawachi T; Nakadate H; Kaneko Y; Masaki Z; Mukai T; Soejima H
    J Biochem; 2003 Mar; 133(3):303-8. PubMed ID: 12761165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. WT1 gene analysis in sporadic early-onset and bilateral wilms tumor patients without associated abnormalities.
    Perotti D; Mondini P; Terenziani M; Spreafico F; Collini P; Fossati-Bellani F; Radice P
    J Pediatr Hematol Oncol; 2005 Apr; 27(4):197-201. PubMed ID: 15838390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel WT1 gene mutation associated with wilms' tumor and congenital male genitourinary malformation.
    Sakamoto J; Takata A; Fukuzawa R; Kikuchi H; Sugiyama M; Kanamori Y; Hashizume K; Hata JI
    Pediatr Res; 2001 Sep; 50(3):337-44. PubMed ID: 11518820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Classification of a frameshift/extended and a stop mutation in WT1 as gain-of-function mutations that activate cell cycle genes and promote Wilms tumour cell proliferation.
    Busch M; Schwindt H; Brandt A; Beier M; Görldt N; Romaniuk P; Toska E; Roberts S; Royer HD; Royer-Pokora B
    Hum Mol Genet; 2014 Aug; 23(15):3958-74. PubMed ID: 24619359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel frame shift mutations ('A' deletion) observed in exon 9 of Wilms' tumor (WT1) gene in a patient reported with glomerulosclerosis.
    Pasupuleti SK; Katari V; Lokanathan S; Uppu VP; Thummaginjala SS; Akkamgari RP; Ayapati T; Kottu R; Potukuchi VG
    Gene; 2014 Aug; 546(1):63-7. PubMed ID: 24853201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of Wilms' tumor gene 1 (WT1) in desmoid tumors.
    Amini Nik S; Hohenstein P; Jadidizadeh A; Van Dam K; Bastidas A; Berry RL; Patek CE; Van der Schueren B; Cassiman JJ; Tejpar S
    Int J Cancer; 2005 Mar; 114(2):202-8. PubMed ID: 15540161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
    Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA
    Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between a specific Wilms tumour suppressor gene (WT1) mutation and the histological findings in Wilms tumour (WT).
    Shibata R; Hashiguchi A; Sakamoto J; Yamada T; Umezawa A; Hata J
    J Med Genet; 2002 Dec; 39(12):e83. PubMed ID: 12471221
    [No Abstract]   [Full Text] [Related]  

  • 35. Identification and analysis of mutations in WTX and WT1 genes in peripheral blood and tumor tissue of children with Wilms' tumor.
    Wang H; Shen Y; Sun N; Jiang YP; Li ML; Sun L
    Chin Med J (Engl); 2012 May; 125(10):1733-9. PubMed ID: 22800892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children's Oncology Group Study.
    Gadd S; Huff V; Huang CC; Ruteshouser EC; Dome JS; Grundy PE; Breslow N; Jennings L; Green DM; Beckwith JB; Perlman EJ
    Neoplasia; 2012 Aug; 14(8):742-56. PubMed ID: 22952427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular and epidemiologic characterization of Wilms tumor from Baghdad, Iraq.
    Phelps HM; Al-Jadiry MF; Corbitt NM; Pierce JM; Li B; Wei Q; Flores RR; Correa H; Uccini S; Frangoul H; Alsaadawi AR; Al-Badri SAF; Al-Darraji AF; Al-Saeed RM; Al-Hadad SA; Lovvorn Iii HN
    World J Pediatr; 2018 Dec; 14(6):585-593. PubMed ID: 30155617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis.
    Pritchard-Jones K; Fleming S
    Oncogene; 1991 Dec; 6(12):2211-20. PubMed ID: 1722569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of heterozygosity of WT1 gene in the prognosis of sporadic Wilms' tumour in children.
    Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
    Anticancer Res; 1999; 19(2B):1451-4. PubMed ID: 10365122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No difference in the occurrence of mismatch repair defects and APC and CTNNB1 genes mutation in a multi-racial colorectal carcinoma patient cohort.
    Tan LP; Ng BK; Balraj P; Lim PK; Peh SC
    Pathology; 2007 Apr; 39(2):228-34. PubMed ID: 17454753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.